Michael Robert Hohnadel, DO | |
864 Central Blvd, Suite 3000, Brownsville, TX 78520-7551 | |
(956) 546-7546 | |
(956) 546-7544 |
Full Name | Michael Robert Hohnadel |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 22 Years |
Location | 864 Central Blvd, Brownsville, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477646537 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | L7420 (Texas) | Primary |
Entity Name | Rio Valley Dermatology, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548491863 PECOS PAC ID: 7517013204 Enrollment ID: O20090922000404 |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Friday awarded Zimbabwe $37.9 million to help fight the three diseases, "and in an unusual move handed the money directly to the new unity government," the Associated Press reports.
In northern latitudes, producers of bedding plants depend on supplemental lighting during the late winter and early spring growing seasons. Unfortunately, these peak times for young plant production are also the darkest. Researchers have determined that a minimum amount of photosynthetic light (daily light integral; DLI) is necessary to produce high-quality young plants in greenhouses. In northern latitudes, though, the average greenhouse photosynthetic DLI can fall far short of optimal levels, resulting in delayed production and poor quality plants.
A recent study revealed that endovascular repair of complex aortic aneurysms using fenestrated and branched endografts provides a safe and effective alternative to open surgical repair, with the lowest ever reported mortality rate in this patient population, according to researchers at The University of Texas Health Science Center at Houston and Memorial Hermann Heart and Vascular Institute Aortic Center.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Robert Hohnadel, DO 864 Central Blvd, Suite 3000, Brownsville, TX 78520-7551 Ph: (956) 546-7546 | Michael Robert Hohnadel, DO 864 Central Blvd, Suite 3000, Brownsville, TX 78520-7551 Ph: (956) 546-7546 |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Friday awarded Zimbabwe $37.9 million to help fight the three diseases, "and in an unusual move handed the money directly to the new unity government," the Associated Press reports.
In northern latitudes, producers of bedding plants depend on supplemental lighting during the late winter and early spring growing seasons. Unfortunately, these peak times for young plant production are also the darkest. Researchers have determined that a minimum amount of photosynthetic light (daily light integral; DLI) is necessary to produce high-quality young plants in greenhouses. In northern latitudes, though, the average greenhouse photosynthetic DLI can fall far short of optimal levels, resulting in delayed production and poor quality plants.
A recent study revealed that endovascular repair of complex aortic aneurysms using fenestrated and branched endografts provides a safe and effective alternative to open surgical repair, with the lowest ever reported mortality rate in this patient population, according to researchers at The University of Texas Health Science Center at Houston and Memorial Hermann Heart and Vascular Institute Aortic Center.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 5 days ago